Psoriasis: Perspectives

 
 
  • Non-Pharmacologic Therapies in PsO and PsA: 5 Things to Know While pharmacologic therapies remain central to managing PsO and PsA, non-pharmacologic interventions also play a crucial role in enhancing treatment outcomes and improving patients' quality of life.
  • S3 Episode 2: For Psoriasis, Should Dermatologists Treat Obesity?   Join Drs Steven Feldman and Robert Kushner as they discuss the role of dermatologists in treating obesity in conjunction with psoriasis.
  • S3 Episode 1: Cost, Coverage, and Psoriasis: Overcoming Care Barriers   Join Drs Steven Feldman and Jules Lipoff as they discuss teledermatology, the cost of prescriptions, and other barriers to care people with psoriasis face.
  • AAD 2025 Read clinically focused news coverage of key developments from AAD 2025
  • Psoriasis: Presentation, Imitators, and Treatment Psoriasis is a disfiguring and often painful skin condition that affects an estimated 125 million people worldwide. Know the facts about this dermatologic issue.
  • MauiDerm 2025 Read clinically focused news coverage of key developments from MauiDerm 2025
  • More Than Hives: Discussing Chronic Spontaneous Urticaria   Dermatologists discuss common roadblocks in communicating with patients with chronic spontaneous urticaria, who often search for a cause they can fix for a condition lacking in community resources.
  • Navigating PsA Treatment in Patients with Comorbidities PsA often coexists with a range of comorbidities, which can complicate treatment decisions. By tailoring treatment strategies, clinicians can improve outcomes for their patients.
  • The Role of Ultrasound in Psoriatic Arthritis Diagnosis Dr Philip J. Mease shares his insights on the use of ultrasound in psoriatic arthritis diagnosis, particularly in uncovering cases that are not obvious.
  • SDPA 2024 Read clinically focused news coverage of key developments from SDPA 2024
  • Psoriatic Disease and MASLD: What Is the Connection?   Dr Danielle Brandman explores the impact of metabolic dysfunction–associated steatotic liver disease (MASLD) in individuals with psoriatic disease.
  • Are Genes Responsible for Causing Psoriasis? Research on the role that genes play in psoriasis has led to targeted therapies to reduce symptoms and slow disease progression.
  • A Patient-Centered Focus in Crohn's Disease Management Although several treatment options exist in the management of Crohn's disease, a patient-centered approach is integral amid the challenges of addressing symptoms and optimizing patient care.
  • Comorbidities Associated With Psoriasis: 5 Things to Know Psoriasis-associated comorbidities can have a significant impact on a patient's quality of life. Clinicians should be aware of these co-existing conditions for screening and appropriate co-management.
  • Managing Long-Term Plaque Psoriasis   Biologic therapies revolutionized treatment of plaque psoriasis. Recent clinical studies provide data on long-term safety and efficacy of several therapies used in moderate to severe plaque psoriasis.
  • EADV 2024 Read clinically focused news coverage of key developments from EADV 2024
  • The NPF and the Future of Psoriatic Disease   National Psoriasis Foundation president and CEO Leah McCormick Howard discusses NPF resources to improve the lives of individuals living with psoriatic disease.
  • IBD Treatment Options After Failure of First-Line   When first-line anti–tumor necrosis factor treatment of inflammatory bowel disease fails, numerous options may be used in second-line. Dr Bincy Abraham discusses factors that inform the optimal choice.
  • The Role of Cytokines in Psoriasis: 5 Things to Know Research on the role that cytokines play in psoriasis has led to targeted therapies to reduce symptoms and slow disease progression.
  • Phototherapy for Psoriasis: When Is It the Right Choice?   Drs Tina Bhutani, Mona Shahriari, and Jason Hawkes discuss the use of phototherapy in the treatment of psoriasis as they work toward optimal outcomes in patient care.